QEII Health Sciences Centre — Halifax, Nova Scotia

Public research footprint of QEII Health Sciences Centre, compiled from the ClinicalTrials.gov public registry.

251

Registered studies

Active

Recruiting now

128

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Myelodysplastic Syndrome · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT07415044 — LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis (Recruiting)
NCT06872892 — The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at QEII Health Sciences Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.